FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3115083642> ?p ?o ?g. }

• W3115083642 endingPage "2122" @default.
• W3115083642 startingPage "2106" @default.
• W3115083642 abstract "Timely and objective diagnosis and classification of mastitis is crucial to ensure adequate management and therapeutic decisions. Analyzing specific biomarkers in milk could be advantageous compared with subjective or semiquantitative criteria, such as palpation of the udder in clinical mastitis cases or evaluation of somatic cell count using cow side tests (e.g., California Mastitis Test) in subclinical mastitis quarters. The objective of this study was to investigate the diagnostic value of 3 biomarkers; cathelicidin, milk amyloid A, and haptoglobin for the diagnosis of subclinical and clinical mastitis. Furthermore, the suitability of these biomarkers to differentiate between mild, moderate, and severe clinical mastitis and the influence of different pathogens on biomarker levels was tested. A total of 67 healthy cows, 119 cows with subclinical mastitis, and 212 cows with clinical mastitis were enrolled in the study. Although cathelicidin, haptoglobin, and milk amyloid A were measured in all samples from healthy cows and those with subclinical mastitis, haptoglobin, and cathelicidin results were only available from 121 out of 212 cows with clinical mastitis. Milk amyloid A was measured in all samples. In cows with clinical mastitis, the mastitic quarter and a second healthy quarter serving as a healthy in-cow control quarter were sampled. It was possible to differentiate between healthy quarters, quarters with subclinical mastitis, and quarters with clinical mastitis using all 3 biomarkers. Concerning cathelicidin, thresholds were 0.000 [sensitivity (Se) = 0.83, specificity (Sp) = 0.97] and 0.053 (Se = 0.98, Sp = 0.99) for normalized optical density at 450 nm (NOD450) for differentiating between healthy quarters and quarters with subclinical or clinical mastitis, respectively. Thresholds of 1.28 µg/mL (Se = 0.65, Sp = 0.76) and 1.81 µg/mL (Se = 0.77, Sp = 0.83) for milk amyloid A and 3.65 µg/mL (Se = 0.92, Sp = 0.94) and 5.40 µg/mL mL (Se = 0.96, Sp = 0.99) for haptoglobin were calculated, respectively. Healthy in-cow control quarters from cows with CM showed elevated milk amyloid A and haptoglobin levels compared with healthy quarters from healthy cows. Only the level of milk amyloid A was higher in severe clinical mastitis cases compared with mild ones. In contrast to clinical mastitis, cathelicidin and haptoglobin in subclinical mastitis quarters were significantly influenced by different bacteriological results. The measurement of cathelicidin, milk amyloid A, and haptoglobin in milk proved to be a reliable method to detect quarters with subclinical or clinical mastitis." @default.
• W3115083642 created "2021-01-05" @default.
• W3115083642 creator A5012357211 @default.
• W3115083642 creator A5038219790 @default.
• W3115083642 creator A5043157126 @default.
• W3115083642 creator A5051663477 @default.
• W3115083642 creator A5070943531 @default.
• W3115083642 creator A5072815678 @default.
• W3115083642 creator A5088827571 @default.
• W3115083642 date "2021-02-01" @default.
• W3115083642 modified "2023-10-01" @default.
• W3115083642 title "The value of the biomarkers cathelicidin, milk amyloid A, and haptoglobin to diagnose and classify clinical and subclinical mastitis" @default.
• W3115083642 cites W1964916811 @default.
• W3115083642 cites W1967275472 @default.
• W3115083642 cites W1979218309 @default.
• W3115083642 cites W1979461688 @default.
• W3115083642 cites W1987558430 @default.
• W3115083642 cites W1999396942 @default.
• W3115083642 cites W2001911792 @default.
• W3115083642 cites W2009008029 @default.
• W3115083642 cites W2010347178 @default.
• W3115083642 cites W2021948592 @default.
• W3115083642 cites W2039139862 @default.
• W3115083642 cites W2039254920 @default.
• W3115083642 cites W2039768186 @default.
• W3115083642 cites W2040282922 @default.
• W3115083642 cites W2055551138 @default.
• W3115083642 cites W2060483617 @default.
• W3115083642 cites W2065683366 @default.
• W3115083642 cites W2080352933 @default.
• W3115083642 cites W2083186077 @default.
• W3115083642 cites W2089272566 @default.
• W3115083642 cites W2089374897 @default.
• W3115083642 cites W2100711331 @default.
• W3115083642 cites W2101489834 @default.
• W3115083642 cites W2107140020 @default.
• W3115083642 cites W2108664562 @default.
• W3115083642 cites W2113181674 @default.
• W3115083642 cites W2113770154 @default.
• W3115083642 cites W2114973943 @default.
• W3115083642 cites W2119293827 @default.
• W3115083642 cites W2132681751 @default.
• W3115083642 cites W2135665764 @default.
• W3115083642 cites W2145487709 @default.
• W3115083642 cites W2146470488 @default.
• W3115083642 cites W2151314772 @default.
• W3115083642 cites W2152249293 @default.
• W3115083642 cites W2158354038 @default.
• W3115083642 cites W2158526498 @default.
• W3115083642 cites W2160246764 @default.
• W3115083642 cites W2165160511 @default.
• W3115083642 cites W2170215539 @default.
• W3115083642 cites W2174010568 @default.
• W3115083642 cites W2182172429 @default.
• W3115083642 cites W2182569851 @default.
• W3115083642 cites W2215673818 @default.
• W3115083642 cites W2411267745 @default.
• W3115083642 cites W2415059568 @default.
• W3115083642 cites W2463134043 @default.
• W3115083642 cites W2508316128 @default.
• W3115083642 cites W2558660515 @default.
• W3115083642 cites W2581142237 @default.
• W3115083642 cites W2583612421 @default.
• W3115083642 cites W2685314616 @default.
• W3115083642 cites W2745444965 @default.
• W3115083642 cites W2769668997 @default.
• W3115083642 cites W2789279602 @default.
• W3115083642 cites W2804364761 @default.
• W3115083642 cites W2808598265 @default.
• W3115083642 doi "https://doi.org/10.3168/jds.2020-18539" @default.
• W3115083642 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33358157" @default.
• W3115083642 hasPublicationYear "2021" @default.
• W3115083642 type Work @default.
• W3115083642 sameAs 3115083642 @default.
• W3115083642 citedByCount "11" @default.
• W3115083642 countsByYear W31150836422021 @default.
• W3115083642 countsByYear W31150836422022 @default.
• W3115083642 countsByYear W31150836422023 @default.
• W3115083642 crossrefType "journal-article" @default.
• W3115083642 hasAuthorship W3115083642A5012357211 @default.
• W3115083642 hasAuthorship W3115083642A5038219790 @default.
• W3115083642 hasAuthorship W3115083642A5043157126 @default.
• W3115083642 hasAuthorship W3115083642A5051663477 @default.
• W3115083642 hasAuthorship W3115083642A5070943531 @default.
• W3115083642 hasAuthorship W3115083642A5072815678 @default.
• W3115083642 hasAuthorship W3115083642A5088827571 @default.
• W3115083642 hasBestOaLocation W31150836421 @default.
• W3115083642 hasConcept C113280763 @default.
• W3115083642 hasConcept C126322002 @default.
• W3115083642 hasConcept C142724271 @default.
• W3115083642 hasConcept C203014093 @default.
• W3115083642 hasConcept C206396517 @default.
• W3115083642 hasConcept C22641795 @default.
• W3115083642 hasConcept C2776344049 @default.
• W3115083642 hasConcept C2776659692 @default.
• W3115083642 hasConcept C2776792119 @default.
• W3115083642 hasConcept C2776921810 @default.
• W3115083642 hasConcept C2779234561 @default.

• next